Fresenius Medical Care (NYSE:FMS) Shares Gap Down to $20.54

Fresenius Medical Care AG (NYSE:FMS) shares gapped down before the market opened on Thursday . The stock had previously closed at $20.54, but opened at $20.03. Fresenius Medical Care shares last traded at $19.90, with a volume of 34,753 shares traded.

Analyst Ratings Changes

A number of analysts have commented on FMS shares. Truist Financial cut their price target on shares of Fresenius Medical Care from $24.00 to $22.00 and set a “hold” rating for the company in a research note on Wednesday, July 31st. StockNews.com started coverage on Fresenius Medical Care in a research report on Saturday. They set a “strong-buy” rating on the stock. One analyst has rated the stock with a sell rating, two have assigned a hold rating, one has given a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat.com, the company has a consensus rating of “Hold” and a consensus price target of $22.00.

Fresenius Medical Care Stock Performance

The company’s fifty day simple moving average is $19.45 and its 200 day simple moving average is $19.88. The company has a quick ratio of 1.09, a current ratio of 1.46 and a debt-to-equity ratio of 0.45. The stock has a market capitalization of $12.38 billion, a price-to-earnings ratio of 23.70, a P/E/G ratio of 1.09 and a beta of 0.90.

Fresenius Medical Care (NYSE:FMS) last released its quarterly earnings results on Tuesday, July 30th. The company reported $0.38 earnings per share for the quarter, meeting the consensus estimate of $0.38. Fresenius Medical Care had a net margin of 2.72% and a return on equity of 5.48%. The firm had revenue of $5.13 billion for the quarter, compared to analysts’ expectations of $5.28 billion. On average, equities research analysts expect that Fresenius Medical Care AG will post 1.51 earnings per share for the current year.

Institutional Trading of Fresenius Medical Care

Several institutional investors have recently added to or reduced their stakes in the company. GAMMA Investing LLC lifted its holdings in shares of Fresenius Medical Care by 21.8% during the first quarter. GAMMA Investing LLC now owns 4,230 shares of the company’s stock worth $82,000 after buying an additional 758 shares in the last quarter. QRG Capital Management Inc. grew its position in shares of Fresenius Medical Care by 19.5% during the 1st quarter. QRG Capital Management Inc. now owns 54,363 shares of the company’s stock worth $1,048,000 after purchasing an additional 8,870 shares in the last quarter. SG Americas Securities LLC increased its holdings in shares of Fresenius Medical Care by 50.0% during the first quarter. SG Americas Securities LLC now owns 15,228 shares of the company’s stock worth $294,000 after purchasing an additional 5,078 shares during the period. Legacy Wealth Asset Management LLC acquired a new stake in shares of Fresenius Medical Care in the first quarter valued at approximately $584,000. Finally, Assetmark Inc. grew its position in Fresenius Medical Care by 169.9% during the fourth quarter. Assetmark Inc. now owns 4,178 shares of the company’s stock worth $87,000 after buying an additional 2,630 shares in the last quarter. 8.25% of the stock is currently owned by institutional investors.

About Fresenius Medical Care

Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure.